Evidence map›Paper›PMID 35056408›Full record

ReviewMedicina (Kaunas, Lithuania)2022

Global Impact of COVID-19 on Colorectal Cancer Screening: Current Insights and Future Directions.

Jonathan Kopel, Bojana Ristic, Gregory L Brower, Hemant Goyal

Open access · goldAbstract readReview
In one paragraph

Review in Medicina (Kaunas, Lithuania), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.4field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Impact of COVID-19 Pandemic on Performance of Gastrointestinal Endoscopy.The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi · 2023
    Article
  10. Observational
  11. Article
  12. Review
  13. Therapeutic Landscapes in Colorectal Carcinoma.Medicina (Kaunas, Lithuania) · 2023
    Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Jonathan KopelDepartment of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA.ORCID 0000-0001-5934-2695
Bojana RisticCell Biology and Biochemistry, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA.
Gregory L BrowerDepartment of Medication Education, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA.ORCID 0000-0003-4764-1844
Hemant GoyalThe Wright Center for Graduate Medical Education, Scranton, PA 18501, USA.ORCID 0000-0002-9433-9042
Texas Tech University · USThe Wright Center for Graduate Medical Education · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The coronavirus disease 2019 (COVID-19) pandemic has brought significant challenges to many aspects of healthcare delivery since the first reported case in early December 2019. Once in the body, SARS-CoV-2 can spread to other digestive organs, such as the liver, because of the presence of ACE2 receptors. Colorectal cancer (CRC) remains the second-leading cause of death in the United States (US). Therefore, individuals are routinely screened using either endoscopic methods (i.e., flexible sigmoidoscopy and colonoscopy) or stool-based tests, as per the published guidelines. At the beginning of the COVID-19 pandemic, the Centers for Medicare and Medicaid Services (CMS) recommended that all non-urgent surgical and medical procedures, including screening colonoscopies, be delayed until the pandemic stabilization. This article aims to review the impact of COVID-19 on CRC screening.

Indexed as

Colorectal NeoplasmsCOVID-19AgedEarly Detection of CancerHumansMedicarePandemicsSARS-CoV-2United Statescolorectal cancer screeningCOVID-19SARS-CoV-2

Identifiers

PMID35056408
PMCPMC8778776
OpenAlexW4205635903

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.